CVS•benzinga•
CVS Caremark To Place Novo Nordisk's Wegovy On Preferred Coverage For GLP-1 Weight Loss Treatment
Summary
Wegovy to become preferred GLP-1 drug on CVS Caremark's top formularies in 2025 as Novo Nordisk expands patient access initiatives.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 1, 2025 by benzinga